Search

Our financial information, reports and accounts.

The annual Alzheimer University (AU) assists emerging Alzheimer and dementia associations.

Aduhelm (aducanumab) is the first new dementia drug treatment to come to market since 2003.

The month of March has marked significant progress in the development and implementation of National Dementia Plans (NDPs), with the #WhatsYourPlan campaign leading to the launch of plans in Uruguay and Armenia, bringing the total number of WHO Member States with NDPs to 41.

On 14 May 2019 the World Health Organization (WHO) launched new Guidelines on risk reduction of cognitive decline and dementia. This report provides evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia.

DY Suharya, Director of ADI Asia Pacific, and Shyh Poh Teo, Director of Demensia Brunei, reflect on the 2023 Asia Pacific Regional Conference as co-organisers of the event. 

Through successful completion of training, carers, their trainers and providers of training programmes can earn ADI Accreditation.

The 33rd International Conference of Alzheimer's Disease International was held in July 2018 in Chicago, USA

This report concludes the two year direct action campaign and highlights 2023 #WhatsYourPlan campaign progress, aiming to galvanise governments to commit to implementing National Dementia Plans.

ADI is excited to announce that Paola Barbarino has been appointed as our new CEO. Paola will assume the role on 15 May 2017, after which there will be a period of transition alongside outgoing Executive Director, Marc Wortmann. Marc will be leaving his position after more than ten years…